Joseph Sleiman

738 total citations
39 papers, 487 citations indexed

About

Joseph Sleiman is a scholar working on Oncology, Surgery and Epidemiology. According to data from OpenAlex, Joseph Sleiman has authored 39 papers receiving a total of 487 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 12 papers in Surgery and 10 papers in Epidemiology. Recurrent topics in Joseph Sleiman's work include Colorectal Cancer Treatments and Studies (9 papers), Cancer Immunotherapy and Biomarkers (8 papers) and Inflammatory Bowel Disease (7 papers). Joseph Sleiman is often cited by papers focused on Colorectal Cancer Treatments and Studies (9 papers), Cancer Immunotherapy and Biomarkers (8 papers) and Inflammatory Bowel Disease (7 papers). Joseph Sleiman collaborates with scholars based in United States, Italy and Lebanon. Joseph Sleiman's co-authors include Alì Taher, Pauline Funchain, Maria Domenica Cappellini, Rayan Bou‐Fakhredin, Jessica Philpott, Florian Rieder, Antoine N. Saliba, Rita Chiari, Yinghong Wang and Faisal S. Ali and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Gastroenterology.

In The Last Decade

Joseph Sleiman

31 papers receiving 476 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joseph Sleiman United States 12 211 111 105 85 80 39 487
Yasser Mostafa Kamel United States 10 172 0.8× 84 0.8× 59 0.6× 52 0.6× 25 0.3× 29 546
Michiaki Hirayama Japan 14 169 0.8× 81 0.7× 34 0.3× 40 0.5× 154 1.9× 56 575
Nurdan Taçyıldız Türkiye 11 142 0.7× 58 0.5× 64 0.6× 23 0.3× 79 1.0× 42 492
Martin Bornhaeuser Germany 9 179 0.8× 96 0.9× 77 0.7× 30 0.4× 18 0.2× 49 532
Jae Won Choe South Korea 13 172 0.8× 40 0.4× 63 0.6× 35 0.4× 175 2.2× 24 612
Sabine Boas‐Knoop Germany 16 155 0.7× 31 0.3× 181 1.7× 25 0.3× 217 2.7× 27 663
Daniel Couriel United States 8 141 0.7× 195 1.8× 46 0.4× 35 0.4× 67 0.8× 14 633
Francesca Lim Singapore 12 138 0.7× 22 0.2× 34 0.3× 39 0.5× 75 0.9× 49 350
Hiroki Mizuno Japan 11 118 0.6× 23 0.2× 29 0.3× 59 0.7× 72 0.9× 106 454
Jingjing Shang China 14 196 0.9× 20 0.2× 59 0.6× 31 0.4× 45 0.6× 63 486

Countries citing papers authored by Joseph Sleiman

Since Specialization
Citations

This map shows the geographic impact of Joseph Sleiman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph Sleiman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph Sleiman more than expected).

Fields of papers citing papers by Joseph Sleiman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joseph Sleiman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph Sleiman. The network helps show where Joseph Sleiman may publish in the future.

Co-authorship network of co-authors of Joseph Sleiman

This figure shows the co-authorship network connecting the top 25 collaborators of Joseph Sleiman. A scholar is included among the top collaborators of Joseph Sleiman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joseph Sleiman. Joseph Sleiman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sleiman, Joseph, et al.. (2025). Unveiling Tirzepatide’s Therapeutic Spectrum: A Dual GIP/GLP‐1 Agonist Targeting Metabolic, Neurological, and Cardiovascular Health. International Journal of Endocrinology. 2025(1). 2876156–2876156.
2.
Sleiman, Joseph. (2025). All you need to know about the overlap between primary sclerosing cholangitis and inflammatory bowel disease. Annals of Gastroenterology. 38(2). 107–120.
3.
Sleiman, Joseph, et al.. (2024). Navigating the “First Gastroenterology Job” Search for American and International Medical Graduates. Digestive Diseases and Sciences. 69(9). 3122–3127.
4.
Sleiman, Joseph, et al.. (2024). Part II: Contract Negotiation and Job Preparation–The Gastroenterology Perspective. Digestive Diseases and Sciences. 69(9). 3128–3133. 1 indexed citations
5.
Sleiman, Joseph, James Bena, Shannon Morrison, et al.. (2023). Incidence and prevalence of advanced colorectal neoplasia in Lynch syndrome. Gastrointestinal Endoscopy. 98(3). 412–419.e8. 5 indexed citations
6.
7.
Sleiman, Joseph, Muhammad Zarrar Khan, Benjamin L. Cohen, et al.. (2023). Sweet Syndrome Associated with Active Inflammatory Bowel Disease: A Case Series of a Rare Extra-intestinal Manifestation. Digestive Diseases and Sciences. 68(9). 3562–3568. 1 indexed citations
8.
Faisal, Muhammad Salman, Daniela Allende, Joseph Sleiman, et al.. (2023). Characteristics of Immune Checkpoint Inhibitor-Associated Gastritis: Report from a Major Tertiary Care Center. The Oncologist. 28(8). 706–713. 11 indexed citations
9.
Ouali, Sara El, Mark E. Baker, Cathy Lu, et al.. (2023). Tu1787 VEDOLIZUMAB AS A MEDICAL THERAPY FOR SYMPTOMATIC STRICTURING SMALL BOWEL CROHN'S DISEASE - RESULTS FROM AN INTERNATIONAL MULTICENTER COHORT STUDY. Gastroenterology. 164(6). S–1128. 1 indexed citations
10.
Sleiman, Joseph, et al.. (2023). DOP12 Validation of radiomics features on MR enterography characterizing inflammation and fibrosis in stricturing Crohn’s disease. Journal of Crohn s and Colitis. 17(Supplement_1). i73–i73. 2 indexed citations
11.
Sleiman, Joseph, Rhonda M. Brand, Reetesh K. Pai, et al.. (2023). Mirroring UC care pathways in refractory immune checkpoint inhibitor (ICI)-mediated colitis: distinct features and common pathways. Clinical Journal of Gastroenterology. 16(5). 680–684. 6 indexed citations
12.
Sleiman, Joseph, Namita Gandhi, Mark E. Baker, et al.. (2022). Crohn's disease related strictures in cross‐sectional imaging: More than meets the eye?. United European Gastroenterology Journal. 10(10). 1167–1178. 16 indexed citations
13.
Gupta, Shilpa, C.A. Reddy, Dana E. Angelini, et al.. (2022). Thromboembolism in Patients with Metastatic Urothelial Cancer Treated with Immune Checkpoint Inhibitors. Targeted Oncology. 17(5). 563–569. 9 indexed citations
14.
Sleiman, Joseph, Ruishen Lyu, Amit Bhatt, et al.. (2021). Clinically actionable findings on surveillance EGD in asymptomatic patients with Lynch syndrome. Gastrointestinal Endoscopy. 95(1). 105–114. 14 indexed citations
15.
Gupta, Shilpa, C.A. Reddy, Dana E. Angelini, et al.. (2021). Thromboembolism in Patients with Metastatic Renal Cell Carcinoma Treated with Immunotherapy. Targeted Oncology. 16(6). 813–821. 9 indexed citations
16.
Sleiman, Joseph, et al.. (2021). Teaching residents how to break bad news: piloting a resident-led curriculum and feedback task force as a proof-of-concept study. BMJ Simulation & Technology Enhanced Learning. 7(6). 568–574. 2 indexed citations
17.
Sleiman, Joseph, et al.. (2018). Renal Complications in Thalassemia. SHILAP Revista de lepidopterología. 8(1). 7481–7481. 9 indexed citations
18.
Sleiman, Joseph, et al.. (2007). SPONTANEOUS ESCHERICHIA COLI CELLULITIS IN A CHILD WITH NEPHROTIC SYNDROME. The Pediatric Infectious Disease Journal. 26(3). 266–267. 6 indexed citations
19.
Contencin, P, et al.. (1999). Nasal Fossae Dimensions in the Neonate and Young Infant. Archives of Otolaryngology - Head and Neck Surgery. 125(7). 777–777. 23 indexed citations
20.
Ayache, Denis, et al.. (1999). Obliterative otosclerosis. The Journal of Laryngology & Otology. 113(6). 512–514. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yasser Mostafa Kamel Breakdown of academic impact, for papers by Michiaki Hirayama Breakdown of academic impact, for papers by Nurdan Taçyıldız Breakdown of academic impact, for papers by Martin Bornhaeuser Breakdown of academic impact, for papers by Jae Won Choe Breakdown of academic impact, for papers by Sabine Boas‐Knoop Breakdown of academic impact, for papers by Daniel Couriel Breakdown of academic impact, for papers by Francesca Lim Breakdown of academic impact, for papers by Hiroki Mizuno Breakdown of academic impact, for papers by Jingjing Shang
Rankless by CCL
2026